CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
143 hedge funds and large institutions have $1.86B invested in Clovis Oncology, Inc. in 2014 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 57 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more funds holding
Funds holding: 138 → 143 (+5)
17% less call options, than puts
Call options by funds: $22.6M | Put options by funds: $27.2M
Holders
143
Holding in Top 10
9
Calls
$22.6M
Puts
$27.2M
Top Buyers
| 1 | +$52.9M | |
| 2 | +$40M | |
| 3 | +$31M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$28.2M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$25.5M |
Top Sellers
| 1 | -$65.5M | |
| 2 | -$12M | |
| 3 | -$10.2M | |
| 4 |
CCI
Columbus Circle Investors
|
-$9.29M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$8.7M |